Cargando...
Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
BACKGROUND: Patients who have had a venous thromboembolic event are generally advised to receive anticoagulant treatment for 3 months or longer to prevent a recurrent episode. Current guidelines recommend initial heparin and an oral vitamin K antagonist (VKA) for long-term anticoagulation. However,...
Gardado en:
| Publicado en: | Vasc Health Risk Manag |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4754098/ https://ncbi.nlm.nih.gov/pubmed/26929637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S88088 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|